- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06606262
재발성 급성 편도선염 치료에서 편도선 절제술과 편도선 절제술 비교
재발성 급성 편도선염 치료에서 편도선 절제술과 편도선 절제술 비교: 무작위 대조 비열등성 시험
Background: recurrent acute tonsillitis (RT) is a frequent condition affecting teenagers and adults. Patients suffer from recurring throat symptoms, fever and impaired quality of life (QOL). Tonsillectomy (TE) is the only well-known treatment, but studies indicate that tonsillotomy (TO) is associated with less morbidity (eg. pain and bleeding) and equal efficiency (e.g. reduced number of sore throat episodes and improved QOL). The investigator aim to clarify whether TO is a non-inferior alternative to TE.
Methods: inclusion and randomization of 250 adult RT patients for TE or TO with a 12 month follow up. Comparisons will be made between groups, and outcome measures includes number of sore throat episodes, QOL and postoperative pain.
Discussion: the study has the potential to improve the treatment of a prevalent disease by enhancing knowledge of an alternative procedure (TO) associated with less discomfort and risk than the current standard procedure (TE) and a presumably low risk of insufficiency.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Aalborg, 덴마크, 9000
- Aalborg University Hospital
-
Aarhus, 덴마크, 8200
- Aarhus University Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adults (age ≥15 years) with RT, defined as a minimum of five tonsillitis episodes in one year or a minimum of three tonsillitis episodes per year for two years (Danish National Guidelines criteria
- The ability to understand Danish orally and in writing.
Exclusion Criteria:
- Previous TE or TO.
- Suspected tonsillar malignancy.
- History of malignant tumor in the oral cavity, the pharynx or the larynx.
- Previous radiation therapy on head or neck.
- Hemorrhagic diathesis or anticoagulant therapy.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Tonsillotomy
A potential non-inferior surgical procedure for treating recurrent acute tonsillitis. |
Bilateral partial removal of the palatine tonsils to a level between the pharyngeal pillars and the tonsillar capsule. Surgery will be performed under general anesthesia using monopolar electrocautery.
다른 이름들:
|
|
활성 비교기: Tonsillectomy
The current standard surgical procedure for treating recurrent acute tonsillitis. |
Bilateral extracapsular removal of palatine tonsils. Surgery will be performed under general anesthesia using "cold knife" dissection.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
TE 대 TO 후 인후통 에피소드 수.
기간: 12개월(및 24, 36, 60개월)
|
12개월(및 24, 36, 60개월)
|
|
|
QOL measured as postoperative Tonsillectomy Outcome Inventory 14 (TOI-14) score after TE vs. TO
기간: 12 months (and 24, 36 and 60 months)
|
A disease-specific questionnaire for adults with tonsillitis. It is used pre- and postoperatively to detect changes in quality of life. It consists of 14 questions that covers four subscales: throat dis-comfort (question 1-4) general health (question 5-6), resources (question 7-10), and social psychological restrictions (question 11-14). The questionnaire uses a six-point Likert scale with 0 representing "no problem" and 5 representing "couldn't be worse". The points are summed, divided by the number of questions multiplied by 5, and multiplied by 100, giving scores in the range 0-100, where higher scores reflect poorer quality of life |
12 months (and 24, 36 and 60 months)
|
|
Summarized postoperative pain scores (days 1-10)
기간: Days 1-10
|
Measured on a numeric rating scale from 0 til 10 in which 0 represents "no pain" and 10 represents "excruciating pain" |
Days 1-10
|
|
Overall postoperative discomfort (day 21)
기간: Day 21
|
Measured on a numeric rating scale from 0 til 10 in which 0 represents "no discomfort" and 10 represents "excruciating discomfort" |
Day 21
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
TE 대 TO 후 치료된 환자의 비율(수술 후 TOI-14<15로 정의됨)
기간: 12개월(및 24, 36, 60개월)
|
12개월(및 24, 36, 60개월)
|
|
|
TE 대 TO 후 인후통 일수
기간: 12개월(및 24, 36, 60개월)
|
12개월(및 24, 36, 60개월)
|
|
|
TE 대 TO 후 재수술의 빈도
기간: 12개월(및 24, 36, 60개월)
|
12개월(및 24, 36, 60개월)
|
|
|
Overall patient satisfaction after TE vs. TO
기간: 12 months (and 24, 36 and 60 months)
|
Patients will be asked the following question: "Keeping in mind your full experience and the effects of surgery so far, are you satisfied with having undergone surgery?. Possible answers are 1) "yes", 2) "no" and 3) "I don't know" |
12 months (and 24, 36 and 60 months)
|
|
Postoperative Glasgow Benefit Inventory (GBI) score after TE vs. TO
기간: 12 months (and 24, 36 and 60 months)
|
A generic questionnaire for otorhinolaryngological interventions. It is used post-intervention to detect changes in quality of life. It consists of 18 questions that covers three subscales: a general health sub-scale (question 1-6, 9-10, 14, 16-18), a social support subscale (question 7, 11 and 15) and a physical health subscale (question 8, 12-13). The questionnaire uses a five-point Likert scale with 1 representing "worst change of health status" and 5 representing "best change of health status". The points are summed and divided by the number of questions (resulting in average scores), and by subtracting 3 and multiplying by 50, the final scores range from -100 to +100. 0 indicates no change, higher scores reflect better quality of life |
12 months (and 24, 36 and 60 months)
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .